Study 12 of 2431 for search of: received on or after 11/14/2008
Previous Study Return to Search Results Next Study

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Treatment Of Radiation Retinopathy Trial (TORR)
This study is enrolling participants by invitation only.
Study NCT00811200.   Last updated on December 17, 2008.
Information provided by Leiden University Medical Center
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Uveal Melanoma
Additional conditions recognized in this trial
Melanoma
Retinal Diseases
More general conditions related to this trial
Eye Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Interventions listed in this trial
ranibizumab
triamcinolone acetonide
sham
Additional drug interventions recognized in this trial
Triamcinolone
Triamcinolone diacetate
Triamcinolone hexacetonide
More general drug interventions related to this trial
Anti-Inflammatory Agents
Enzyme Inhibitors
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Leiden University Medical Center
Novartis Pharmaceuticals


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services